From fatty liver to nonalcoholic steatohepatitis (NASH), glucose utilization in muscle deteriorates progressively, and hyperinsulinemia are not secondary to a decrease in hepatic insulin extraction [46,47,48]. The gene discussed is INS; the disease is metabolic dysfunction-associated steatohepatitis.